Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Inspira Technologies OXY B.H.N. Ltd. (IINN : NSDQ)
 
 • Company Description   
Inspira Technologies OXY B.H.N. Ltd is a specialty medical device company. It engaged in the research, development, manufacture and marketing of proprietary respiratory support technology. Inspira Technologies OXY B.H.N. Ltd is based in RA'ANANA, Israel.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.79 Daily Weekly Monthly
20 Day Moving Average: 55,710 shares
Shares Outstanding: 7.80 (millions)
Market Capitalization: $13.95 (millions)
Beta:
52 Week High: $6.48
52 Week Low: $1.66
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -24.47% -17.55%
12 Week -35.84% -30.66%
Year To Date -56.97% -49.03%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
HATIDHAR 2 11TH FLOOR
-
RAANANA,L3 4366504
ISR
ph: 972-4623-0333
fax: -
None http://inspira-technologies.com
 
 • General Corporate Information   
Officers
Dagi Ben-Noon - Chief Executive Officer; Director
Prof. Benad Goldwasser - Chairman of the Board of Directors
Joe Hayon - Chief Financial Officer; President; Director
Avi Shabtai - Chief Operations Officer and VP of Research and De
Lior Amit - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: M53637100
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: 06/30/22
Share - Related Items
Shares Outstanding: 7.80
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $13.95 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.84 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/30/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.69
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 5.68
09/30/21 - 4.11
Quick Ratio
03/31/22 - -
12/31/21 - 5.68
09/30/21 - 4.11
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 2.61
09/30/21 - 1.71
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.06
09/30/21 - 0.04
Debt-to-Capital
03/31/22 - -
12/31/21 - 5.58
09/30/21 - 3.64
 

Powered by Zacks Investment Research ©